NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Modulight Biotherapeutics

Modulight Biotherapeutics

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.modulight.bio/

Last Round

Seed

Nov 12, 2025

Total Funding Raised

$12.2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Modulight Biotherapeutics is a biotechnology company developing a precision neuromodulation platform using optogenetics to treat severe neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

optogeneticsgene therapyneuromodulationprecision medicineneural circuitslight-activated proteinseOPN3neurological disordersneurotechbio-electronicsdrug discoveryepilepsy treatmentneuropathic painbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Modulight Biotherapeutics Comparables

Compare Modulight Biotherapeutics with similar companies based on industry and business-model similarity.

Modulight Biotherapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Opsin Biotherapeutics
81%
Kriya Therapeutics
74%
Circuit Therapeutics, Inc.
74%

Modulight Biotherapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 12, 2025

Key People

Founding team and executive leadership

Ofer Yizhar

Chief Scientific Officer, Co-founder

Founding Team

Yotam Eldar

CEO Co-founder

Founding Team

Modulight Biotherapeutics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors increased 32% MoM, reaching 2K.

Modulight Biotherapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Modulight Biotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Modulight Biotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range23
Year Founded2022
Last FundingNov 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.